Loyal portfolio

Insybio logo

Insybio

Healthcare / Medical / Biomed · United States

Follow OnUnited StatesINSEADSDG 3
Konstantinos TheofilatosL

Konstantinos Theofilatos · Labros Digonis

About Insybio

We drive innovation in both clinical trials and drug discovery and, through our proprietary AI empowered platform, are a leading company in targeted biomarker discovery for fields such as Cancer, Nutrition, Infectious and Neurodegenerative diseases. Through this we enable precision medicine.

Visit website

In the news

  • Oct 12

    InSyBio recaps its Python workshop, guiding researchers through mass-spectrometry and multi-omics analysis workflows.

    View on LinkedIn

Founders

  • Konstantinos Theofilatos

    Konstantinos Theofilatos

  • L

    Labros Digonis

Details

Stage
Follow On
Sector
Healthcare / Medical / Biomed, AI / Machine Learning
Country
United States
Region
United States
Source
INSEAD
UN SDGs
SDG 3